ReP USP - Resultado da busca

Artigo de periodico
Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response (2023)
Borges, Bruno Montanari ; Ramos, Rafael Berton Correia ; Preite, Nycolas Willian ; Kaminski, Valéria de Lima ; Camacho, Maurício ; Campos, Claudia Barbosa Ladeira de; Zelanis, André ; Loures, Flavio Vieira ; Castro, Patrícia Alves de; Maximo, Marina Ferreira ; Fill, Taicia Pacheco ; Traynor, Aimee M. ; Özlem Sarikaya-Bayram ; Sean Doyle ; Bayram, Özgür ; Goldman, Gustavo Henrique ; Calich, Vera Lúcia Garcia
Source: Frontiers in Cellular and Infection Microbiology. Unidades: FCFRP, ICB
Subjects: IMUNOLOGIA, GRANULOMA, PARACOCCIDIOIDOMICOSE, PARACOCCIDIOIDES, PROTEÔMICA, FERRO, CAMUNDONGOS ENDOGÂMICOS C57BL, TRANSCRIÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Bruno Montanari et al. Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response. Frontiers in Cellular and Infection Microbiology, v. 13, p. 27 , 2023Tradução . . Disponível em: https://doi/org/10.3389/fcimb.2023.1268959. Acesso em: 05 nov. 2024.
APA
Borges, B. M., Ramos, R. B. C., Preite, N. W., Kaminski, V. de L., Camacho, M., Campos, C. B. L. de, et al. (2023). Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response. Frontiers in Cellular and Infection Microbiology, 13, 27 . doi:10.3389/fcimb.2023.1268959
NLM
Borges BM, Ramos RBC, Preite NW, Kaminski V de L, Camacho M, Campos CBL de, Zelanis A, Loures FV, Castro PA de, Maximo MF, Fill TP, Traynor AM, Özlem Sarikaya-Bayram, Sean Doyle, Bayram Ö, Goldman GH, Calich VLG. Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response [Internet]. Frontiers in Cellular and Infection Microbiology. 2023 ; 13 27 .[citado 2024 nov. 05 ] Available from: https://doi/org/10.3389/fcimb.2023.1268959
Vancouver
Borges BM, Ramos RBC, Preite NW, Kaminski V de L, Camacho M, Campos CBL de, Zelanis A, Loures FV, Castro PA de, Maximo MF, Fill TP, Traynor AM, Özlem Sarikaya-Bayram, Sean Doyle, Bayram Ö, Goldman GH, Calich VLG. Transcriptional profiling of a fungal granuloma reveals a low metabolic activity of Paracoccidioides brasiliensis yeasts and an actively regulated host immune response [Internet]. Frontiers in Cellular and Infection Microbiology. 2023 ; 13 27 .[citado 2024 nov. 05 ] Available from: https://doi/org/10.3389/fcimb.2023.1268959
Artigo de periodico
Virtual ontogeny of cortical growth preceding mental illness (2022)
Patel, Yash; Shin, Jean; Abé, Christoph ; Agartz, Ingrid ; Alloza, Clara ; Alnæs, Dag ; Ambrogi, Sonia ; Antonucci, Linda A. ; Arango, Celso ; Volker Arolt ; Guillaume Auzias ; Ayesa-Arriola, Rosa ; Banaj, Nerisa ; Banaschewski, Tobias ; Bandeira, Cibele ; Cupertino, Renata Basso ; Bau, Claiton H. D. ; Bauer, Jochen ; Baumeister, Sarah ; Paus, Tomas ; Bernardoni, Fabio ; Bertolino, Alessandro ; Bonnin, Caterina del Mar ; Brandeis, Daniel; Brem, Silvia ; Bruggemann, Jason ; Bülow, Robin ; Bustillo, Juan R. ; Calderoni, Sara ; Calvo, Rosa ; Canales-Rodríguez, Erick J. ; Cannon, Dara M. ; Carmona, Susanna ; Carr, Vaughan J. ; Catts, Stanley Victor ; Chenji, Sneha ; Chew, Qian Hui ; Coghill, David ; Connolly, Colm G. ; Conzelmann, Annette ; Craven, Alexander R. ; Crespo-Facorro, Benedicto ; Cullen, Kathryn ; Dahl, Andreas ; Dannlowski, Udo ; Davey, Christopher G.; Deruelle, Christine ; Díaz-Caneja, Covadonga M. ; Dohm, Katarina ; Ehrlich, Stefan ; Epstein, Jeffery ; Erwin-Grabner, Tracy; Eyler, Lisa T. ; Fedor, Jennifer; Fitzgerald, Jacqueline ; Foran, William ; Ford, Judith M. ; Fortea, Lydia ; Fuentes-Claramonte, Paola ; Fullerton, Janice ; Furlong, Lisa ; Gallagher, Louise ; Gao, Bingchen ; Gao, Si; Goikolea, Jose M. ; Gotlib, Ian H. ; Goya-Maldonado, Roberto ; Grabe, Hans J. ; Green, Melissa J. ; Grevet, Eugenio H. ; Groenewold, Nynke A. ; Grotegerd, Dominik ; Gruber, Oliver; Haavik, Jan ; Hahn, Tim; Harrison, Ben J. ; Heindel, Walter ; Henskens, Frans ; Heslenfeld, Dirk J.; Howells, Fleur M. ; Hilland, Eva ; Hoekstra, Pieter J. ; Hohmann, Sara ; Holz, Nathalie; Ipser, Jonathan C. ; Jahanshad, Neda ; Jakobi, Babette ; Jansen, Andreas; Janssen, Joost ; Rune Jonassen, Rune ; Kaiser, Anna; Kaleda, Vasiliy; Karantonis, James ; King, Joseph A. ; Kircher, Tilo ; Kochunov, Peter ; Koopowitz, Sheri-Michelle ; Landén, Mikael ; Nils, Inge Landrø ; Lawrie, Stephem ; Lebedeva, Irina ; Luna, Neatriz ; Lundervold, Astri J. ; MacMaster, Frank P. ; Maglanoc, Luigi A. ; Mathalon, Daniel H. ; McDonald, Colm ; Rovaris, Diego Luiz
Source: Biological Psychiatry. Unidade: ICB
Subjects: FISIOLOGIA, TRANSTORNO BIPOLAR, TRANSTORNO AUTÍSTICO, TRANSTORNO DO DEFICIT DE ATENÇÃO COM HIPERATIVIDADE, TRANSTORNO DO ESPECTRO AUTISTA, CÓRTEX CEREBRAL, SISTEMA NERVOSO CENTRAL, DEPRESSÃO, RESSONÂNCIA MAGNÉTICA, TRANSTORNO DISTÍMICO, ONTOGENIA, DOENÇAS DO SISTEMA NERVOSO CENTRAL, TRANSTORNOS MENTAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PATEL, Yash et al. Virtual ontogeny of cortical growth preceding mental illness. Biological Psychiatry, v. 92, n. 4, p. 299-313, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.biopsych.2022.02.959. Acesso em: 05 nov. 2024.
APA
Patel, Y., Shin, J., Abé, C., Agartz, I., Alloza, C., Alnæs, D., et al. (2022). Virtual ontogeny of cortical growth preceding mental illness. Biological Psychiatry, 92( 4), 299-313. doi:10.1016/j.biopsych.2022.02.959
NLM
Patel Y, Shin J, Abé C, Agartz I, Alloza C, Alnæs D, Ambrogi S, Antonucci LA, Arango C, Volker Arolt, Guillaume Auzias, Ayesa-Arriola R, Banaj N, Banaschewski T, Bandeira C, Cupertino RB, Bau CHD, Bauer J, Baumeister S, Paus T, Bernardoni F, Bertolino A, Bonnin C del M, Brandeis D, Brem S, Bruggemann J, Bülow R, Bustillo JR, Calderoni S, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carmona S, Carr VJ, Catts SV, Chenji S, Chew QH, Coghill D, Connolly CG, Conzelmann A, Craven AR, Crespo-Facorro B, Cullen K, Dahl A, Dannlowski U, Davey CG, Deruelle C, Díaz-Caneja CM, Dohm K, Ehrlich S, Epstein J, Erwin-Grabner T, Eyler LT, Fedor J, Fitzgerald J, Foran W, Ford JM, Fortea L, Fuentes-Claramonte P, Fullerton J, Furlong L, Gallagher L, Gao B, Gao S, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Haavik J, Hahn T, Harrison BJ, Heindel W, Henskens F, Heslenfeld DJ, Howells FM, Hilland E, Hoekstra PJ, Hohmann S, Holz N, Ipser JC, Jahanshad N, Jakobi B, Jansen A, Janssen J, Rune Jonassen R, Kaiser A, Kaleda V, Karantonis J, King JA, Kircher T, Kochunov P, Koopowitz S-M, Landén M, Nils IL, Lawrie S, Lebedeva I, Luna N, Lundervold AJ, MacMaster FP, Maglanoc LA, Mathalon DH, McDonald C, Rovaris DL. Virtual ontogeny of cortical growth preceding mental illness [Internet]. Biological Psychiatry. 2022 ; 92( 4): 299-313.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.biopsych.2022.02.959
Vancouver
Patel Y, Shin J, Abé C, Agartz I, Alloza C, Alnæs D, Ambrogi S, Antonucci LA, Arango C, Volker Arolt, Guillaume Auzias, Ayesa-Arriola R, Banaj N, Banaschewski T, Bandeira C, Cupertino RB, Bau CHD, Bauer J, Baumeister S, Paus T, Bernardoni F, Bertolino A, Bonnin C del M, Brandeis D, Brem S, Bruggemann J, Bülow R, Bustillo JR, Calderoni S, Calvo R, Canales-Rodríguez EJ, Cannon DM, Carmona S, Carr VJ, Catts SV, Chenji S, Chew QH, Coghill D, Connolly CG, Conzelmann A, Craven AR, Crespo-Facorro B, Cullen K, Dahl A, Dannlowski U, Davey CG, Deruelle C, Díaz-Caneja CM, Dohm K, Ehrlich S, Epstein J, Erwin-Grabner T, Eyler LT, Fedor J, Fitzgerald J, Foran W, Ford JM, Fortea L, Fuentes-Claramonte P, Fullerton J, Furlong L, Gallagher L, Gao B, Gao S, Goikolea JM, Gotlib IH, Goya-Maldonado R, Grabe HJ, Green MJ, Grevet EH, Groenewold NA, Grotegerd D, Gruber O, Haavik J, Hahn T, Harrison BJ, Heindel W, Henskens F, Heslenfeld DJ, Howells FM, Hilland E, Hoekstra PJ, Hohmann S, Holz N, Ipser JC, Jahanshad N, Jakobi B, Jansen A, Janssen J, Rune Jonassen R, Kaiser A, Kaleda V, Karantonis J, King JA, Kircher T, Kochunov P, Koopowitz S-M, Landén M, Nils IL, Lawrie S, Lebedeva I, Luna N, Lundervold AJ, MacMaster FP, Maglanoc LA, Mathalon DH, McDonald C, Rovaris DL. Virtual ontogeny of cortical growth preceding mental illness [Internet]. Biological Psychiatry. 2022 ; 92( 4): 299-313.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.biopsych.2022.02.959
Artigo de periodico
Pediocin PA-1 production by Pediococcus pentosaceus ET34 using non-detoxified hemicellulose hydrolysate obtained from hydrothermal pretreatment of sugarcane bagasse (2021)
Kuniyoshi, Taís Mayumi ; Mendonça, Carlos Miguel Nóbrega ; Vieira, Viviane Borges; Robl, Diogo ; Franco, Bernadette Dora Gombossy de Melo ; Todorov, Svetoslav Dimitrov ; Tomé, Elisabetta; O\2019Connor, Paula Mary; Converti, Attilio ; Araújo, Welington Luiz de ; Vasconcellos, Lívia Paula Silva Palmeiras; Varani, Alessandro de Mello ; Cotter, Paul David ; Rabelo, Sarita Candida ; Oliveira, Ricardo Pinheiro de Souza
Source: Bioresource Technology. Unidades: FCF, ICB
Subjects: BAGAÇOS, CANA-DE-AÇÚCAR, INFECÇÕES BACTERIANAS, CONSERVANTES, PEPTÍDEOS, POLISSACARÍDEOS BACTERIANOS, BACTÉRIAS GRAM-POSITIVAS, GENOMAS, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUNIYOSHI, Taís Mayumi et al. Pediocin PA-1 production by Pediococcus pentosaceus ET34 using non-detoxified hemicellulose hydrolysate obtained from hydrothermal pretreatment of sugarcane bagasse. Bioresource Technology, v. 338, p. 1-12 art. 125565, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.biortech.2021.125565. Acesso em: 05 nov. 2024.
APA
Kuniyoshi, T. M., Mendonça, C. M. N., Vieira, V. B., Robl, D., Franco, B. D. G. de M., Todorov, S. D., et al. (2021). Pediocin PA-1 production by Pediococcus pentosaceus ET34 using non-detoxified hemicellulose hydrolysate obtained from hydrothermal pretreatment of sugarcane bagasse. Bioresource Technology, 338, 1-12 art. 125565. doi:10.1016/j.biortech.2021.125565
NLM
Kuniyoshi TM, Mendonça CMN, Vieira VB, Robl D, Franco BDG de M, Todorov SD, Tomé E, O\2019Connor PM, Converti A, Araújo WL de, Vasconcellos LPSP, Varani A de M, Cotter PD, Rabelo SC, Oliveira RP de S. Pediocin PA-1 production by Pediococcus pentosaceus ET34 using non-detoxified hemicellulose hydrolysate obtained from hydrothermal pretreatment of sugarcane bagasse [Internet]. Bioresource Technology. 2021 ; 338 1-12 art. 125565.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.biortech.2021.125565
Vancouver
Kuniyoshi TM, Mendonça CMN, Vieira VB, Robl D, Franco BDG de M, Todorov SD, Tomé E, O\2019Connor PM, Converti A, Araújo WL de, Vasconcellos LPSP, Varani A de M, Cotter PD, Rabelo SC, Oliveira RP de S. Pediocin PA-1 production by Pediococcus pentosaceus ET34 using non-detoxified hemicellulose hydrolysate obtained from hydrothermal pretreatment of sugarcane bagasse [Internet]. Bioresource Technology. 2021 ; 338 1-12 art. 125565.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.biortech.2021.125565
Artigo de periodico
INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies (2021)
Haren, Frank M.P. van ; Richardson, Alice ; Yoon, Hwan‐Jin ; Artigas, Antonio ; Laffey, John G. ; Dixon, Barry; Smith, Roger; Vilaseca, Alicia B. ; Barbera, Ruben A.; Ismail, Tarek I.; Mahrous, Rabab S. ; Badr, Mohamed ; De Nucci, Gilberto ; Sverdloff, Carlos; Loon, Lex M. van ; Rimblas, Marta Camprubi ; Cosgrave, David W. ; Smoot, Thomas L. ; Staas, Sabrina; Sann, Khine ; Sas, Caitlin; Belani, Anusha; Hillman, Christopher; Shute, Janis ; Carroll, Mary; Wilkinson, Tom ; Carroll, Miles ; Singh, Dave; Page, Clive
Source: British Journal of Clinical Pharmacology (Print). Unidade: ICB
Subjects: FARMACOLOGIA, COVID-19, DOENÇAS RESPIRATÓRIAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, POLISSACARÍDEOS, INFECÇÕES RESPIRATÓRIAS, INFECÇÕES POR VÍRUS DE RNA, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAREN, Frank M.P. van et al. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies. British Journal of Clinical Pharmacology (Print), p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14714. Acesso em: 05 nov. 2024.
APA
Haren, F. M. P. van, Richardson, A., Yoon, H. ‐J., Artigas, A., Laffey, J. G., Dixon, B., et al. (2021). INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies. British Journal of Clinical Pharmacology (Print), 1-17. doi:10.1111/bcp.14714
NLM
Haren FMP van, Richardson A, Yoon H‐J, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, Loon LM van, Rimblas MC, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies [Internet]. British Journal of Clinical Pharmacology (Print). 2021 ; 1-17.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcp.14714
Vancouver
Haren FMP van, Richardson A, Yoon H‐J, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, Loon LM van, Rimblas MC, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID‐19 (INHALE‐HEP): protocol and statistical analysis plan for an investigator‐initiated international metatrial of randomised studies [Internet]. British Journal of Clinical Pharmacology (Print). 2021 ; 1-17.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/bcp.14714
Artigo de periodico-carta/editorial
Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Su, Helen C. ; Casanova, Jean-Laurent ; Spaan, András N. ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41590-021-01096-9. Acesso em: 05 nov. 2024. , 2021
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41590-021-01096-9
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 05 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 05 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Draft genome sequence of a Pseudomonas aeruginosa sequence Type 3351 strain exhibiting high-level resistance to polymyxins in a pediatric patient with cystic fibrosis in Mexico (2020)
Reys, Roberto Rosales; Esposito, Fernanda Ribeiro dos Santos ; Araújo, Bruna Fuga; Cerdeira, Louise Teixeira ; Vázquez, Catalina Gayosso; Fernández, José L. Lezana; Lascurain, Ricardo ; Valvano, Miguel A. ; Lincopan, Nilton ; Preciado, José I. Santos
Source: Microbiology Resource Announcements. Unidades: ICB, FCF
Subjects: BIOFILMES, FIBROSE CÍSTICA, GENOMAS, MUTAÇÃO GENÉTICA, POLIMIXINAS, PSEUDOMONAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REYS, Roberto Rosales et al. Draft genome sequence of a Pseudomonas aeruginosa sequence Type 3351 strain exhibiting high-level resistance to polymyxins in a pediatric patient with cystic fibrosis in Mexico. Microbiology Resource Announcements, v. 9, n. 2, p. 3 , 2020Tradução . . Disponível em: https://doi.org/10.1128/MRA.01261-19. Acesso em: 05 nov. 2024.
APA
Reys, R. R., Esposito, F. R. dos S., Araújo, B. F., Cerdeira, L. T., Vázquez, C. G., Fernández, J. L. L., et al. (2020). Draft genome sequence of a Pseudomonas aeruginosa sequence Type 3351 strain exhibiting high-level resistance to polymyxins in a pediatric patient with cystic fibrosis in Mexico. Microbiology Resource Announcements, 9( 2), 3 . doi:10.1128/MRA.01261-19
NLM
Reys RR, Esposito FR dos S, Araújo BF, Cerdeira LT, Vázquez CG, Fernández JLL, Lascurain R, Valvano MA, Lincopan N, Preciado JIS. Draft genome sequence of a Pseudomonas aeruginosa sequence Type 3351 strain exhibiting high-level resistance to polymyxins in a pediatric patient with cystic fibrosis in Mexico [Internet]. Microbiology Resource Announcements. 2020 ; 9( 2): 3 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.1128/MRA.01261-19
Vancouver
Reys RR, Esposito FR dos S, Araújo BF, Cerdeira LT, Vázquez CG, Fernández JLL, Lascurain R, Valvano MA, Lincopan N, Preciado JIS. Draft genome sequence of a Pseudomonas aeruginosa sequence Type 3351 strain exhibiting high-level resistance to polymyxins in a pediatric patient with cystic fibrosis in Mexico [Internet]. Microbiology Resource Announcements. 2020 ; 9( 2): 3 .[citado 2024 nov. 05 ] Available from: https://doi.org/10.1128/MRA.01261-19
Artigo de periodico
Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis (2017)
Nascimento, Ivan Pereira; Rodriguez, Dúnia; Santos, Carina Carvalho dos; Amaral, Eduardo Pinheiro; Rofatto, Henrique Krambeck; Junqueira-Kipnis, Ana Paula; Gonçalves, Eduardo Dantas Casillo; Lima, Maria Regina D'Império ; Hirata, Mario Hiroyuki ; Silva, Célio Lopes; Winter, Nathalie; Gicquel, Brigitte; Mills, Kingston H G; Pizza, Mariagrazia; Rappuoli, Rino; Leite, Luciana C. C
Source: Scientific Reports. Unidades: ICB, FCF, FMRP
Subjects: IMUNOLOGIA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, VACINAS, CITOCININAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Ivan Pereira et al. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, v. 7, n. 1, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-02003-9. Acesso em: 05 nov. 2024.
APA
Nascimento, I. P., Rodriguez, D., Santos, C. C. dos, Amaral, E. P., Rofatto, H. K., Junqueira-Kipnis, A. P., et al. (2017). Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, 7( 1), 1-11. doi:10.1038/s41598-017-02003-9
NLM
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Vancouver
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Artigo de periodico
Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery (2017)
Clemente, Tiago; Vieira, Narcisio J.; Cerliani, Juan P.; Adrain, Colin; Luthi, Alexander; Dominguez, Mariana R.; Yon, Monica; Barrence, Fernanda C; Riul, Thalita B.; Cummings, Richard D.; Zorn, Telma M.; Amigorena, Sebastian; Dias-Baruffi, Marcelo; Rodrigues, Maurício M.; Martin, Seamus J.; Rabinovich, Gabriel A.; Amarante-Mendes, João Gustavo Pessini
Source: Cell Death & Disease. Unidade: ICB
Subjects: HISTOLOGIA, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CLEMENTE, Tiago et al. Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery. Cell Death & Disease, v. 8, n. 12, p. 1-10, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2017.05.059. Acesso em: 05 nov. 2024.
APA
Clemente, T., Vieira, N. J., Cerliani, J. P., Adrain, C., Luthi, A., Dominguez, M. R., et al. (2017). Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery. Cell Death & Disease, 8( 12), 1-10. doi:10.1016/j.celrep.2017.05.059
NLM
Clemente T, Vieira NJ, Cerliani JP, Adrain C, Luthi A, Dominguez MR, Yon M, Barrence FC, Riul TB, Cummings RD, Zorn TM, Amigorena S, Dias-Baruffi M, Rodrigues MM, Martin SJ, Rabinovich GA, Amarante-Mendes JGP. Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery [Internet]. Cell Death & Disease. 2017 ; 8( 12): 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.celrep.2017.05.059
Vancouver
Clemente T, Vieira NJ, Cerliani JP, Adrain C, Luthi A, Dominguez MR, Yon M, Barrence FC, Riul TB, Cummings RD, Zorn TM, Amigorena S, Dias-Baruffi M, Rodrigues MM, Martin SJ, Rabinovich GA, Amarante-Mendes JGP. Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery [Internet]. Cell Death & Disease. 2017 ; 8( 12): 1-10.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.celrep.2017.05.059

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration